These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

629 related items for PubMed ID: 20033321

  • 1. Impact of the peritoneal surface disease severity score on survival in patients with colorectal cancer peritoneal carcinomatosis undergoing complete cytoreduction and hyperthermic intraperitoneal chemotherapy.
    Chua TC, Morris DL, Esquivel J.
    Ann Surg Oncol; 2010 May; 17(5):1330-6. PubMed ID: 20033321
    [Abstract] [Full Text] [Related]

  • 2. Cytoreductive surgery and perioperative intraperitoneal chemotherapy for isolated colorectal peritoneal carcinomatosis: experimental therapy or standard of care?
    Yan TD, Morris DL.
    Ann Surg; 2008 Nov; 248(5):829-35. PubMed ID: 18948811
    [Abstract] [Full Text] [Related]

  • 3. Complete cytoreduction offers longterm survival in patients with peritoneal carcinomatosis from appendiceal tumors of unfavorable histology.
    Omohwo C, Nieroda CA, Studeman KD, Thieme H, Kostuik P, Ross AS, Holter DR, Gushchin V, Merriman B, Sardi A.
    J Am Coll Surg; 2009 Sep; 209(3):308-12. PubMed ID: 19717034
    [Abstract] [Full Text] [Related]

  • 4. Long-term survival of peritoneal carcinomatosis of colorectal origin.
    Verwaal VJ, van Ruth S, Witkamp A, Boot H, van Slooten G, Zoetmulder FA.
    Ann Surg Oncol; 2005 Jan; 12(1):65-71. PubMed ID: 15827780
    [Abstract] [Full Text] [Related]

  • 5. Recurrences after peritoneal carcinomatosis of colorectal origin treated by cytoreduction and hyperthermic intraperitoneal chemotherapy: location, treatment, and outcome.
    Verwaal VJ, Boot H, Aleman BM, van Tinteren H, Zoetmulder FA.
    Ann Surg Oncol; 2004 Apr; 11(4):375-9. PubMed ID: 15070596
    [Abstract] [Full Text] [Related]

  • 6. 8-year follow-up of randomized trial: cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer.
    Verwaal VJ, Bruin S, Boot H, van Slooten G, van Tinteren H.
    Ann Surg Oncol; 2008 Sep; 15(9):2426-32. PubMed ID: 18521686
    [Abstract] [Full Text] [Related]

  • 7. Failure analysis of recurrent disease following complete cytoreduction and perioperative intraperitoneal chemotherapy in patients with peritoneal carcinomatosis from colorectal cancer.
    Bijelic L, Yan TD, Sugarbaker PH.
    Ann Surg Oncol; 2007 Aug; 14(8):2281-8. PubMed ID: 17503156
    [Abstract] [Full Text] [Related]

  • 8. The American Society of Peritoneal Surface Malignancies evaluation of HIPEC with Mitomycin C versus Oxaliplatin in 539 patients with colon cancer undergoing a complete cytoreductive surgery.
    Prada-Villaverde A, Esquivel J, Lowy AM, Markman M, Chua T, Pelz J, Baratti D, Baumgartner JM, Berri R, Bretcha-Boix P, Deraco M, Flores-Ayala G, Glehen O, Gomez-Portilla A, González-Moreno S, Goodman M, Halkia E, Kusamura S, Moller M, Passot G, Pocard M, Salti G, Sardi A, Senthil M, Spiliotis J, Torres-Melero J, Turaga K, Trout R.
    J Surg Oncol; 2014 Dec; 110(7):779-85. PubMed ID: 25088304
    [Abstract] [Full Text] [Related]

  • 9. Diffuse malignant peritoneal mesothelioma: Failure analysis following cytoreduction and hyperthermic intraperitoneal chemotherapy (HIPEC).
    Baratti D, Kusamura S, Cabras AD, Dileo P, Laterza B, Deraco M.
    Ann Surg Oncol; 2009 Feb; 16(2):463-72. PubMed ID: 19082859
    [Abstract] [Full Text] [Related]

  • 10. Treatment of peritoneal carcinomatosis from colonic cancer by cytoreduction, peritonectomy and hyperthermic intraperitoneal chemotherapy (HIPEC). Experience of ten years.
    Vaira M, Cioppa T, D'Amico S, de Marco G, D'Alessandro M, Fiorentini G, De Simone M.
    In Vivo; 2010 Feb; 24(1):79-84. PubMed ID: 20133981
    [Abstract] [Full Text] [Related]

  • 11. Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer.
    Verwaal VJ, van Ruth S, de Bree E, van Sloothen GW, van Tinteren H, Boot H, Zoetmulder FA.
    J Clin Oncol; 2003 Oct 15; 21(20):3737-43. PubMed ID: 14551293
    [Abstract] [Full Text] [Related]

  • 12. Pseudomyxoma peritonei: clinical pathological and biological prognostic factors in patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC).
    Baratti D, Kusamura S, Nonaka D, Langer M, Andreola S, Favaro M, Gavazzi C, Laterza B, Deraco M.
    Ann Surg Oncol; 2008 Feb 15; 15(2):526-34. PubMed ID: 18043976
    [Abstract] [Full Text] [Related]

  • 13. Critical analysis of 33 patients with peritoneal carcinomatosis secondary to colorectal and appendiceal signet ring cell carcinoma.
    Chua TC, Pelz JO, Kerscher A, Morris DL, Esquivel J.
    Ann Surg Oncol; 2009 Oct 15; 16(10):2765-70. PubMed ID: 19641972
    [Abstract] [Full Text] [Related]

  • 14. Cytoreductive surgery and intraperitoneal chemotherapy for colorectal peritoneal carcinomatosis: prognosis and treatment of recurrences in a cohort study.
    Cashin PH, Graf W, Nygren P, Mahteme H.
    Eur J Surg Oncol; 2012 Jun 15; 38(6):509-15. PubMed ID: 22475555
    [Abstract] [Full Text] [Related]

  • 15. [Peritoneal carcinomatosis of colorectal cancer: cytoreductive surgery and hyperthermic intraperitoneal chemotherapy].
    Königsrainer I, Beckert S, Brücher B, Zieker D, Königsrainer A.
    Dtsch Med Wochenschr; 2011 Sep 15; 136(36):1811-4. PubMed ID: 21882140
    [Abstract] [Full Text] [Related]

  • 16. The role of cytoreductive surgery and heated intraperitoneal chemotherapy (CRS/HIPEC) in patients with high-grade appendiceal carcinoma and extensive peritoneal carcinomatosis.
    El Halabi H, Gushchin V, Francis J, Athas N, Macdonald R, Nieroda C, Studeman K, Sardi A.
    Ann Surg Oncol; 2012 Jan 15; 19(1):110-4. PubMed ID: 21701929
    [Abstract] [Full Text] [Related]

  • 17. [Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal colorectal carcinomatosis: a newly validated standard whose contribution remains to be assessed].
    Pocard M, Boige V.
    Bull Cancer; 2005 Feb 15; 92(2):151-4. PubMed ID: 15749644
    [Abstract] [Full Text] [Related]

  • 18. Critical analysis of treatment failure after complete cytoreductive surgery and perioperative intraperitoneal chemotherapy for peritoneal dissemination from appendiceal mucinous neoplasms.
    Yan TD, Bijelic L, Sugarbaker PH.
    Ann Surg Oncol; 2007 Aug 15; 14(8):2289-99. PubMed ID: 17541772
    [Abstract] [Full Text] [Related]

  • 19. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal and gastrointestinal origin shows acceptable morbidity and high survival.
    Hagendoorn J, van Lammeren G, Boerma D, van der Beek E, Wiezer MJ, van Ramshorst B.
    Eur J Surg Oncol; 2009 Aug 15; 35(8):833-7. PubMed ID: 19019619
    [Abstract] [Full Text] [Related]

  • 20. Cytoreductive surgery (peritonectomy procedures) combined with hyperthermic intraperitoneal chemotherapy (HIPEC) in the treatment of diffuse peritoneal carcinomatosis from ovarian cancer.
    Di Giorgio A, Naticchioni E, Biacchi D, Sibio S, Accarpio F, Rocco M, Tarquini S, Di Seri M, Ciardi A, Montruccoli D, Sammartino P.
    Cancer; 2008 Jul 15; 113(2):315-25. PubMed ID: 18473354
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.